A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India
Condition: Type 2 Diabetes Mellitus Intervention: Drug: Insulin Glargine Sponsor: Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2019 Category: Research Source Type: clinical trials